Follow
Katarzyna Tomczak, PhD
Katarzyna Tomczak, PhD
The University of Texas MD Anderson Cancer Center
Verified email at mdanderson.org
Title
Cited by
Cited by
Year
Review The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge
K Tomczak, P Czerwińska, M Wiznerowicz
Contemporary Oncology/Współczesna Onkologia 2015 (1), 68-77, 2015
36882015
Identification of EMT signaling cross-talk and gene regulatory networks by single-cell RNA sequencing
SAM Abhijeet P. Deshmukh, Suhas V. Vasaikar, Katarzyna Tomczak, Shubham ...
PNAS, 2021
155*2021
TRIM28 and interacting KRAB-ZNFs control self-renewal of human pluripotent stem cells through epigenetic repression of pro-differentiation genes
U Oleksiewicz, M Gładych, AT Raman, H Heyn, E Mereu, ...
Stem cell reports 9 (6), 2065-2080, 2017
802017
TRIM28 multi-domain protein regulates cancer stem cell population in breast tumor development
P Czerwińska, PK Shah, K Tomczak, M Klimczak, S Mazurek, B Sozańska, ...
Oncotarget 8 (1), 863, 2017
602017
Single cell T cell landscape and T cell receptor repertoire profiling of AML in context of PD-1 blockade therapy
HA Abbas, D Hao, K Tomczak, P Barrodia, JS Im, PK Reville, Z Alaniz, ...
Nature communications 12 (1), 6071, 2021
562021
Inhibition of mitochondrial complex I reverses NOTCH1-driven metabolic reprogramming in T-cell acute lymphoblastic leukemia
N Baran, A Lodi, Y Dhungana, S Herbrich, M Collins, S Sweeney, ...
Nature communications 13 (1), 2801, 2022
292022
Chromatin state dynamics confers specific therapeutic strategies in enhancer subtypes of colorectal cancer
E Orouji, AT Raman, AK Singh, A Sorokin, E Arslan, AK Ghosh, J Schulz, ...
Gut 71 (5), 938-949, 2022
292022
Contemp Oncol (Pozn). 2015; 19 (1A): A68
K Tomczak, P Czerwinska, M Wiznerowicz
A77, 0
24
Reprogramming of bivalent chromatin states in NRAS mutant melanoma suggests PRC2 inhibition as a therapeutic strategy
CJ Terranova, M Tang, M Maitituoheti, AT Raman, AK Ghosh, J Schulz, ...
Cell reports 36 (3), 2021
202021
Next-generation immunotherapies to improve anticancer immunity
Y Shi, K Tomczak, J Li, JK Ochieng, Y Lee, C Haymaker
Frontiers in pharmacology 11, 566401, 2021
162021
Immune landscape of a genetically engineered murine model of glioma compared with human glioma
DB Zamler, T Shingu, LM Kahn, K Huntoon, C Kassab, M Ott, K Tomczak, ...
JCI insight 7 (12), 2022
112022
Dysregulation and epigenetic reprogramming of NRF2 signaling axis promote acquisition of cisplatin resistance and metastasis in head and neck squamous cell carcinoma
AA Osman, E Arslan, M Bartels, C Michikawa, A Lindemann, K Tomczak, ...
Clinical Cancer Research 29 (7), 1344-1359, 2023
72023
Review computational characterisation of cancer molecular profiles derived using next generation sequencing
U Oleksiewicz, K Tomczak, J Woropaj, M Markowska, P Stępniak, ...
Contemporary Oncology/Współczesna Onkologia 2015 (1), 78-91, 2015
42015
Genomic Correlates of Outcome in Tumor-Infiltrating Lymphocyte Therapy for Metastatic Melanoma
CA Creasy, YJ Meng, MA Forget, T Karpinets, K Tomczak, C Stewart, ...
Clinical Cancer Research 28 (9), 1911-1924, 2022
32022
Bivalent and broad chromatin domains regulate pro-metastatic drivers in melanoma
C Terranova, M Tang, M Maitituoheti, AT Raman, J Schulz, SB Amin, ...
bioRxiv, 721480, 2019
32019
Tumor thickness in mesothelioma predicts differential response to neoadjuvant therapy and survival
N Zhou, CS Bell, HA Feldman, CL Haymaker, WL Hofstetter, AS Tsao, ...
The Journal of Thoracic and Cardiovascular Surgery 166 (2), 362-371. e9, 2023
22023
Single-cell characterization of acute myeloid leukemia (AML) and its microenvironment identifies signatures of resistance to PD-1 blockade based therapy
HA Abbas, D Hao, K Tomczak, P Barrodia, JS Im, PK Reville, Z Alaniz, ...
Blood 136, 29-31, 2020
22020
Single-cell characterization of acute myeloid leukemia and its microenvironment following PD-1 blockade based therapy
HA Abbas, D Hao, K Tomczak, P Barrodia, JS Im, PK Reville, Z Alaniz, ...
Biorxiv, 2020.09. 03.278309, 2020
22020
Single-cell chromatin accessibility profiling of acute myeloid leukemia reveals heterogeneous lineage composition upon therapy-resistance
H Fan, F Wang, A Zeng, A Murison, K Tomczak, D Hao, FZ Jelloul, ...
Communications Biology 6 (1), 765, 2023
12023
New cellular models of undifferentiated pleomorphic sarcoma and malignant peripheral nerve sheath tumor
AD Bhalla, SM Landers, AK Singh, MG Yeagley, GSB Meyerson, ...
bioRxiv, 2021.05. 13.443902, 2021
12021
The system can't perform the operation now. Try again later.
Articles 1–20